$BEAM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Beam Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Beam Therapeutics Inc.. Get notifications about new insider transactions in Beam Therapeutics Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Option Exercise | M | 1.03 | 6,000 | 6,180 | 396,345 | |
| Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Buy | M | 1.03 | 6,000 | 6,180 | 1,021,429 | 1 M to 1 M (+0.59 %) |
| Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Option Exercise | M | 1.03 | 6,000 | 6,180 | 396,345 | |
| Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 71.79 | 2,994 | 214,939 | 1,015,429 | 1 M to 1 M (-0.29 %) |
| Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Buy | M | 1.03 | 6,000 | 6,180 | 1,021,429 | 1 M to 1 M (+0.59 %) |
| Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 71.38 | 9,869 | 704,449 | 1,018,423 | 1 M to 1 M (-0.96 %) |
| Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 71.79 | 2,994 | 214,939 | 1,015,429 | 1 M to 1 M (-0.29 %) |
| Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 70.23 | 5,595 | 392,937 | 1,028,292 | 1 M to 1 M (-0.54 %) |
| Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 71.38 | 9,869 | 704,449 | 1,018,423 | 1 M to 1 M (-0.96 %) |
| Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 69.02 | 5,079 | 350,553 | 1,033,887 | 1 M to 1 M (-0.49 %) |
| Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 70.23 | 5,595 | 392,937 | 1,028,292 | 1 M to 1 M (-0.54 %) |
| Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 67.90 | 1,463 | 99,338 | 1,038,966 | 1 M to 1 M (-0.14 %) |
| Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 69.02 | 5,079 | 350,553 | 1,033,887 | 1 M to 1 M (-0.49 %) |
| Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 67.90 | 1,463 | 99,338 | 1,038,966 | 1 M to 1 M (-0.14 %) |
| Apr 12 2021 | BEAM | Beam Therapeutics ... | Evans John M. | Chief Executive Off ... | Buy | L | 0.00 | 32 | 0 | 1,040,429 | 1 M to 1 M (0.00 %) |
| Apr 12 2021 | BEAM | Beam Therapeutics ... | Evans John M. | Chief Executive Off ... | Buy | L | 0.00 | 32 | 0 | 1,040,397 | 1 M to 1 M (0.00 %) |
| Apr 12 2021 | BEAM | Beam Therapeutics ... | Evans John M. | Chief Executive Off ... | Buy | L | 0.00 | 33 | 0 | 1,040,365 | 1 M to 1 M (0.00 %) |
| Apr 02 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Option Exercise | A | 80.04 | 138,750 | 11,105,550 | 138,750 | |
| Apr 02 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Grant | A | 0.00 | 69,375 | 0 | 1,040,332 | 971 K to 1 M (+7.15 %) |
| Apr 02 2021 | BEAM | Beam Therapeutics ... | Ciaramella Giuseppe | President & CSO | Option Exercise | A | 80.04 | 50,000 | 4,002,000 | 50,000 | |
| Apr 02 2021 | BEAM | Beam Therapeutics ... | Ciaramella Giuseppe | President & CSO | Option Exercise | M | 0.67 | 4,030 | 2,700 | 265,414 | |
| Apr 02 2021 | BEAM | Beam Therapeutics ... | Ciaramella Giuseppe | President & CSO | Grant | A | 0.00 | 25,000 | 0 | 44,761 | 19.8 K to 44.8 K (+126.51 %) |
| Apr 02 2021 | BEAM | Beam Therapeutics ... | Ciaramella Giuseppe | President & CSO | Buy | M | 0.67 | 4,030 | 2,700 | 19,761 | 15.7 K to 19.8 K (+25.62 %) |
| Apr 02 2021 | BEAM | Beam Therapeutics ... | Burrell Terry-Ann | CFO | Option Exercise | A | 80.04 | 35,000 | 2,801,400 | 35,000 | |
| Apr 02 2021 | BEAM | Beam Therapeutics ... | Burrell Terry-Ann | CFO | Grant | A | 0.00 | 17,500 | 0 | 24,809 | 7.3 K to 24.8 K (+239.43 %) |
| Apr 02 2021 | BEAM | Beam Therapeutics ... | Burow Kristina | Director | Buy | J | 0.00 | 2,011 | 0 | 6,034 | 4 K to 6 K (+49.99 %) |
| Apr 02 2021 | BEAM | Beam Therapeutics ... | Burow Kristina | Director | Sell | J | 0.00 | 200,000 | 0 | 3,521,519 | 3.7 M to 3.5 M (-5.37 %) |
| Apr 02 2021 | BEAM | Beam Therapeutics ... | Burow Kristina | Director | Sell | J | 0.00 | 200,000 | 0 | 3,521,520 | 3.7 M to 3.5 M (-5.37 %) |
| Apr 02 2021 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 4,686 | 0 | 14,053 | 9.4 K to 14.1 K (+50.03 %) |
| Apr 02 2021 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 200,000 | 0 | 3,521,519 | 3.7 M to 3.5 M (-5.37 %) |
| Apr 02 2021 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 200,000 | 0 | 3,521,520 | 3.7 M to 3.5 M (-5.37 %) |
| Apr 02 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 811 | 0 | 2,434 | 1.6 K to 2.4 K (+49.97 %) |
| Apr 02 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 2,555 | 0 | 7,663 | 5.1 K to 7.7 K (+50.02 %) |
| Apr 02 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 200,000 | 0 | 3,521,519 | 3.7 M to 3.5 M (-5.37 %) |
| Apr 02 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 200,000 | 0 | 3,521,520 | 3.7 M to 3.5 M (-5.37 %) |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 4,684 | 0 | 9,367 | 4.7 K to 9.4 K (+100.02 %) |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 200,000 | 0 | 3,721,519 | 3.9 M to 3.7 M (-5.10 %) |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 200,000 | 0 | 3,721,520 | 3.9 M to 3.7 M (-5.10 %) |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 4,683 | 0 | 4,683 | 0 to 4.7 K |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 200,000 | 0 | 3,921,519 | 4.1 M to 3.9 M (-4.85 %) |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 200,000 | 0 | 3,921,520 | 4.1 M to 3.9 M (-4.85 %) |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | Burow Kristina | Director | Buy | J | 0.00 | 2,011 | 0 | 4,023 | 2 K to 4 K (+99.95 %) |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | Burow Kristina | Director | Sell | J | 0.00 | 200,000 | 0 | 3,721,519 | 3.9 M to 3.7 M (-5.10 %) |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | Burow Kristina | Director | Sell | J | 0.00 | 200,000 | 0 | 3,721,520 | 3.9 M to 3.7 M (-5.10 %) |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | Burow Kristina | Director | Buy | J | 0.00 | 2,012 | 0 | 2,012 | 0 to 2 K |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | Burow Kristina | Director | Sell | J | 0.00 | 200,000 | 0 | 3,921,519 | 4.1 M to 3.9 M (-4.85 %) |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | Burow Kristina | Director | Sell | J | 0.00 | 200,000 | 0 | 3,921,520 | 4.1 M to 3.9 M (-4.85 %) |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 813 | 0 | 1,623 | 810 to 1.6 K (+100.37 %) |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 2,555 | 0 | 5,108 | 2.6 K to 5.1 K (+100.08 %) |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 200,000 | 0 | 3,721,519 | 3.9 M to 3.7 M (-5.10 %) |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 200,000 | 0 | 3,721,520 | 3.9 M to 3.7 M (-5.10 %) |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 810 | 0 | 810 | 0 to 810 |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 2,553 | 0 | 2,553 | 0 to 2.6 K |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 200,000 | 0 | 3,921,519 | 4.1 M to 3.9 M (-4.85 %) |
| Mar 22 2021 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 200,000 | 0 | 3,921,520 | 4.1 M to 3.9 M (-4.85 %) |
| Feb 01 2021 | BEAM | Beam Therapeutics ... | FMR LLC | 10% Owner | Buy | J | 0.00 | 356,673 | 0 | 713,347 | 356.7 K to 713.3 K (+100.00 %) |
| Jan 11 2021 | BEAM | Beam Therapeutics ... | Walsh Kathleen E | Director | Option Exercise | A | 101.67 | 11,609 | 1,180,287 | 11,609 | |
| Jan 05 2021 | BEAM | Beam Therapeutics ... | Burrell Terry-Ann | CFO | Option Exercise | M | 13.68 | 25,000 | 342,000 | 357,941 | |
| Jan 05 2021 | BEAM | Beam Therapeutics ... | Burrell Terry-Ann | CFO | Sell | S | 83.89 | 900 | 75,501 | 7,309 | 8.2 K to 7.3 K (-10.96 %) |
| Jan 05 2021 | BEAM | Beam Therapeutics ... | Burrell Terry-Ann | CFO | Sell | S | 83.15 | 7,095 | 589,949 | 8,209 | 15.3 K to 8.2 K (-46.36 %) |
| Jan 05 2021 | BEAM | Beam Therapeutics ... | Burrell Terry-Ann | CFO | Sell | S | 82.44 | 5,296 | 436,602 | 15,304 | 20.6 K to 15.3 K (-25.71 %) |
| Jan 05 2021 | BEAM | Beam Therapeutics ... | Burrell Terry-Ann | CFO | Sell | S | 81.26 | 6,509 | 528,921 | 20,600 | 27.1 K to 20.6 K (-24.01 %) |
| Jan 05 2021 | BEAM | Beam Therapeutics ... | Burrell Terry-Ann | CFO | Sell | S | 80.25 | 2,449 | 196,532 | 27,109 | 29.6 K to 27.1 K (-8.29 %) |
| Jan 05 2021 | BEAM | Beam Therapeutics ... | Burrell Terry-Ann | CFO | Sell | S | 79.21 | 1,951 | 154,539 | 29,558 | 31.5 K to 29.6 K (-6.19 %) |
| Jan 05 2021 | BEAM | Beam Therapeutics ... | Burrell Terry-Ann | CFO | Sell | S | 78.05 | 800 | 62,440 | 31,509 | 32.3 K to 31.5 K (-2.48 %) |
| Jan 05 2021 | BEAM | Beam Therapeutics ... | Burrell Terry-Ann | CFO | Buy | M | 13.68 | 25,000 | 342,000 | 32,309 | 7.3 K to 32.3 K (+342.04 %) |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Ciaramella Giuseppe | President & CSO | Option Exercise | M | 0.67 | 12,000 | 8,040 | 257,444 | |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Ciaramella Giuseppe | President & CSO | Option Exercise | M | 1.03 | 43,842 | 45,157 | 85,946 | |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Ciaramella Giuseppe | President & CSO | Buy | M | 0.67 | 12,000 | 8,040 | 15,731 | 3.7 K to 15.7 K (+321.63 %) |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Ciaramella Giuseppe | President & CSO | Sell | S | 89.66 | 600 | 53,796 | 3,731 | 4.3 K to 3.7 K (-13.85 %) |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Ciaramella Giuseppe | President & CSO | Sell | S | 88.22 | 1,700 | 149,974 | 4,331 | 6 K to 4.3 K (-28.19 %) |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Ciaramella Giuseppe | President & CSO | Sell | S | 86.96 | 769 | 66,872 | 6,031 | 6.8 K to 6 K (-11.31 %) |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Ciaramella Giuseppe | President & CSO | Sell | S | 86.27 | 6,756 | 582,840 | 6,800 | 13.6 K to 6.8 K (-49.84 %) |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Ciaramella Giuseppe | President & CSO | Sell | S | 85.16 | 3,049 | 259,653 | 13,556 | 16.6 K to 13.6 K (-18.36 %) |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Ciaramella Giuseppe | President & CSO | Sell | S | 84.06 | 8,248 | 693,327 | 16,605 | 24.9 K to 16.6 K (-33.19 %) |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Ciaramella Giuseppe | President & CSO | Sell | S | 83.12 | 2,805 | 233,152 | 24,853 | 27.7 K to 24.9 K (-10.14 %) |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Ciaramella Giuseppe | President & CSO | Sell | S | 82.00 | 5,297 | 434,354 | 27,658 | 33 K to 27.7 K (-16.07 %) |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Ciaramella Giuseppe | President & CSO | Sell | S | 80.97 | 8,809 | 713,265 | 32,955 | 41.8 K to 33 K (-21.09 %) |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Ciaramella Giuseppe | President & CSO | Sell | S | 80.12 | 3,510 | 281,221 | 41,764 | 45.3 K to 41.8 K (-7.75 %) |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Ciaramella Giuseppe | President & CSO | Sell | S | 79.03 | 2,299 | 181,690 | 45,274 | 47.6 K to 45.3 K (-4.83 %) |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Ciaramella Giuseppe | President & CSO | Buy | M | 1.03 | 43,842 | 45,157 | 47,573 | 3.7 K to 47.6 K (+1,175.07 %) |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 89.41 | 1,666 | 148,957 | 970,957 | 972.6 K to 971 K (-0.17 %) |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 88.12 | 1,121 | 98,783 | 972,623 | 973.7 K to 972.6 K (-0.12 %) |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 86.79 | 504 | 43,742 | 973,744 | 974.2 K to 973.7 K (-0.05 %) |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 86.21 | 7,196 | 620,367 | 974,248 | 981.4 K to 974.2 K (-0.73 %) |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 85.35 | 1,422 | 121,368 | 981,444 | 982.9 K to 981.4 K (-0.14 %) |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 83.76 | 4,925 | 412,518 | 982,866 | 987.8 K to 982.9 K (-0.50 %) |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 82.33 | 4,100 | 337,553 | 987,791 | 991.9 K to 987.8 K (-0.41 %) |
| Jan 04 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 81.14 | 1,366 | 110,837 | 991,891 | 993.3 K to 991.9 K (-0.14 %) |
| Oct 02 2020 | BEAM | Beam Therapeutics ... | Ciaramella Giuseppe | President & CSO | Option Exercise | M | 0.67 | 3,731 | 2,500 | 269,444 | |
| Oct 02 2020 | BEAM | Beam Therapeutics ... | Ciaramella Giuseppe | President & CSO | Buy | M | 0.67 | 3,731 | 2,500 | 3,731 | 0 to 3.7 K |
| Sep 21 2020 | BEAM | Beam Therapeutics ... | Burrell Terry-Ann | CFO | Option Exercise | M | 13.68 | 7,309 | 99,987 | 382,941 | |
| Sep 21 2020 | BEAM | Beam Therapeutics ... | Burrell Terry-Ann | CFO | Buy | M | 13.68 | 7,309 | 99,987 | 7,309 | 0 to 7.3 K |
| Aug 17 2020 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Option Exercise | M | 1.03 | 115,000 | 118,450 | 402,345 | |
| Aug 17 2020 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Buy | M | 1.03 | 115,000 | 118,450 | 993,257 | 878.3 K to 993.3 K (+13.09 %) |
| Aug 17 2020 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Option Exercise | M | 1.03 | 115,000 | 118,450 | 402,345 | |
| Aug 17 2020 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Buy | M | 1.03 | 115,000 | 118,450 | 993,257 | 878.3 K to 993.3 K (+13.09 %) |
| Aug 11 2020 | BEAM | Beam Therapeutics ... | FMR LLC | 10% Owner | Buy | J | 0.00 | 356,674 | 0 | 356,674 | 0 to 356.7 K |
| Feb 12 2020 | BEAM | Beam Therapeutics ... | FMR LLC | 10% Owner | Option Exercise | C | 0.00 | 9,819,820 | 0 | 0 | |
| Feb 12 2020 | BEAM | Beam Therapeutics ... | FMR LLC | 10% Owner | Option Exercise | C | 0.00 | 21,146,743 | 0 | 0 | |
| Feb 12 2020 | BEAM | Beam Therapeutics ... | FMR LLC | 10% Owner | Option Exercise | C | 0.00 | 297,620 | 0 | 0 | |
| Feb 12 2020 | BEAM | Beam Therapeutics ... | FMR LLC | 10% Owner | Buy | C | 0.00 | 2,189,820 | 0 | 6,971,912 | 4.8 M to 7 M (+45.79 %) |
| Feb 12 2020 | BEAM | Beam Therapeutics ... | FMR LLC | 10% Owner | Buy | C | 0.00 | 4,715,723 | 0 | 4,782,092 | 66.4 K to 4.8 M (+7,105.31 %) |
| Feb 12 2020 | BEAM | Beam Therapeutics ... | FMR LLC | 10% Owner | Buy | C | 0.00 | 66,369 | 0 | 66,369 | 0 to 66.4 K |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | Redmile Group, LLC | 10% Owner | Option Exercise | C | 0.00 | 5,208,333 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | Redmile Group, LLC | 10% Owner | Buy | C | 0.00 | 1,161,458 | 0 | 1,161,458 | 0 to 1.2 M |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | Ciaramella Giuseppe | President & CSO | Option Exercise | A | 17.00 | 510,893 | 8,685,181 | 510,893 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | COOPER GRAHAM K | Director | Option Exercise | A | 17.00 | 31,220 | 530,740 | 31,220 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | Fishman Mark | Director | Option Exercise | C | 0.00 | 1,239 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | Fishman Mark | Director | Option Exercise | C | 0.00 | 15,768 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | Fishman Mark | Director | Buy | C | 0.00 | 17,007 | 0 | 17,007 | 0 to 17 K |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 33,184 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 33,184 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 2,750,335 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 2,750,336 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 1,338,000 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 1,338,000 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 4,121,519 | 0 | 4,121,519 | 0 to 4.1 M |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 4,121,520 | 0 | 4,121,520 | 0 to 4.1 M |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | Burow Kristina | Director | Option Exercise | C | 0.00 | 33,184 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | Burow Kristina | Director | Option Exercise | C | 0.00 | 33,184 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | Burow Kristina | Director | Option Exercise | C | 0.00 | 2,750,335 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | Burow Kristina | Director | Option Exercise | C | 0.00 | 2,750,336 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | Burow Kristina | Director | Option Exercise | C | 0.00 | 1,338,000 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | Burow Kristina | Director | Option Exercise | C | 0.00 | 1,338,000 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | Burow Kristina | Director | Buy | C | 0.00 | 4,121,519 | 0 | 4,121,519 | 0 to 4.1 M |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | Burow Kristina | Director | Buy | C | 0.00 | 4,121,520 | 0 | 4,121,520 | 0 to 4.1 M |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 33,184 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 33,184 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 2,750,335 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 2,750,336 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,338,000 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,338,000 | 0 | 0 | |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | C | 0.00 | 4,121,519 | 0 | 4,121,519 | 0 to 4.1 M |
| Feb 11 2020 | BEAM | Beam Therapeutics ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | C | 0.00 | 4,121,520 | 0 | 4,121,520 | 0 to 4.1 M |
Page: 1